Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes

OBJECTIVE: We investigated the association of plasma amyloid beta (Abeta)40, Abeta42, and total tau (tTau) with the presence of Alzheimer pathological changes in cognitively normal individuals with subjective cognitive decline (SCD). METHODS: We included 248 subjects with SCD (61 ± 9 years, 42% fema...

Descripción completa

Detalles Bibliográficos
Autores principales: Verberk, Inge M. W., Slot, Rosalinde E., Verfaillie, Sander C. J., Heijst, Hans, Prins, Niels D., van Berckel, Bart N. M., Scheltens, Philip, Teunissen, Charlotte E., van der Flier, Wiesje M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282982/
https://www.ncbi.nlm.nih.gov/pubmed/30196548
http://dx.doi.org/10.1002/ana.25334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282982/
https://www.ncbi.nlm.nih.gov/pubmed/30196548
http://dx.doi.org/10.1002/ana.25334

Ejemplares similares